Dingdang Health Tech Grp Ltd (9886) Fair Value & Analysis
Healthcare · HK · Market cap HK$1.2B
Fair value as of: Aug 13, 2026
From 13 valuation models · updated 3 days ago
Share price −16.3% over the past month.
A solid business, screening 61% undervalued on our models.
What matters now
- The price is below even our cautious bear case (HK$0.9600). The market is more pessimistic than our downside scenario.
- Solid quality (63/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
47‑month range HK$0.3300 – HK$12.58 · fair‑value band HK$0.9600 – HK$1.51 · the HK$0.7700 price screens below the HK$1.24 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Dingdang Health Tech Grp Ltd (9886) currently trades at HK$0.7700, while our model-based Fair Value estimate is HK$1.24, implying the stock looks roughly 61.0% undervalued today. The Quality Score stands at 63/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Dingdang Health Tech Grp Ltd generated revenue of HK$4.9B at a net margin of -1.0%. Revenue grew 6.7% year over year. It earns a return on equity of -3.1%. The balance sheet holds a net cash position of HK$175M. Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$0.9600 (bear case) to HK$1.51 (bull case); at HK$0.7700, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 44% below its 52-week high and 56% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -64% fair-value upside, at 61%, 9886 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: Growth DCF (HK$2.19) versus Dividend Discount (HK$0.0700). Highest evidence: Growth DCF (80).
Notify me when 9886 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 63 · Market factors (momentum, volatility) 44
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Dingdang Health Technology Group Ltd. provides digital healthcare services in the People's Republic of China. The company offers online medical consultation through online and supplementary services; chronic diseases and health management; health portfolio management and DOT medication adherence services.
Full company description
Dingdang Health Technology Group Ltd. provides digital healthcare services in the People's Republic of China. The company offers online medical consultation through online and supplementary services; chronic diseases and health management; health portfolio management and DOT medication adherence services. It provides a range of health products through offline retail and online direct sales channels. Dingdang Health Technology Group Ltd. was incorporated in 2014 and is headquartered in Beijing, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Dingdang Health Tech Grp Ltd reported revenue of HK$4.9B in FY2025 versus HK$3.7B in FY2021, a compound +7.4%/yr. Reported net income was −HK$49.0M in FY2025.
Watch 9886: get an alert when its fair value changes →
Peer Group
Health Information Services · 125 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $241.51 | $91.49 | -62% |
| Pro Medicus Limited PME | A$183.71 | A$23.74 | -87% |
| BrightSpring Health Services, Inc BTSG | $59.68 | $21.31 | -64% |
| HealthEquity, Inc HQY | $105.50 | $56.63 | -46% |
| Hinge Health, Inc HNGE | $86.32 | $24.03 | -72% |
| 10x Genomics, Inc TXG | $58.48 | $17.18 | -71% |
| Waystar Holding WAY | $24.54 | $12.86 | -48% |
| XtalPi Holdings 2228 | HK$8.19 | HK$1.04 | -87% |
| Doximity, Inc DOCS | $24.99 | $25.91 | +4% |
| Privia Health Group PRVA | $21.54 | $5.26 | -76% |
Compare Dingdang Health Tech Grp Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Dingdang Health Tech Grp Ltd (9886) overvalued or undervalued?
What is the fair value of 9886?
What is the quality score of 9886?
What is the revenue of Dingdang Health Tech Grp Ltd (9886)?
What is the net profit margin of 9886?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Dingdang Health Tech Grp Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.